𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer

✍ Scribed by Hofstetter, G; Berger, A; Fiegl, H; Slade, N; Zorić, A; Holzer, B; Schuster, E; Mobus, V J; Reimer, D; Daxenbichler, G

Book ID
109971250
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
615 KB
Volume
29
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The p53 positive Bcl-2 negative phenotyp
The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer
✍ Phil Rolland; Ian Spendlove; Zahra Madjid; Emad A. Rakha; Poulam Patel; Ian O. E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 275 KB

## Abstract The purpose of this work was to determine if the immunohistochemical p53 (+) Bcl‐2 (−) phenotype predicts survival in breast cancer patients. Tissue from 819 cases of resected primary breast cancer, presented between 1986 and 1998, were assembled in tissue microarray format. Clinicopath

The novel heterodinucleoside dimer 5-FdU
The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145
✍ R.M.C. Cattaneo-Pangrazzi; H. Schott; R.A. Schwendener 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 2 views

BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1-␤-D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell